ObsEva (NASDAQ:OBSV) Coverage Initiated at StockNews.com

Posted by on Feb 21st, 2025

Stock analysts at StockNews.com started coverage on shares of ObsEva (NASDAQ:OBSV – Get Free Report) in a research report issued on Wednesday. The firm set a “hold” rating on the stock.

ObsEva Price Performance

ObsEva has a 1 year low of $0.08 and a 1 year high of $2.14. The company has a market cap of $7.94 million, a PE ratio of -0.11 and a beta of 0.68.

ObsEva Company Profile

(Get Free Report)

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.

Recommended Stories

Receive News & Ratings for ObsEva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ObsEva and related companies with MarketBeat.com's FREE daily email newsletter.